Chemocentryx (CCXI)

Add to Watchlists
Create an Alert
5.35 +0.05  +0.94% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
CCXI Price Chart
View All Events

CCXI Events

Date Type Description
Mar 13 Misc Chemocentryx Inc Q4 2013 Earning Conference Call
Mar 13 Earnings Chemocentryx Inc Q4 2013 Earning Result. Estimate: -0.24.
Nov 07 Misc Chemocentryx, Inc. To Hold Third Quarter 2013 Financial Results Conference Call on Thursday, November 7, 2013
Nov 07 Earnings Chemocentryx, Inc. To Release Third Quarter 2013 Financial Results. Estimate: -0.26.
Aug 12 Misc Chemocentryx, Inc. To Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 12, 2013
Aug 12 Earnings Chemocentryx Announces Second Quarter 2013 Financial Results. Estimate: -0.29.
May 13 Misc Chemocentryx, Inc. First Quarter 2013 Financial Results Conference Call
May 13 Earnings Chemocentryx, Inc. First Quarter 2013 Financial Results Conference Call. Estimate: -0.28.
View All Performance Charts

CCXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chemocentryx is down 55.56% over the last year vs S&P 500 Total Return up 22.72%, Actelion up 72.03%, and Bioline Rx up 8.51%.

Get Quote for
Advertisement

Portfolio Strategies Featuring CCXI

Did Chemocentryx make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CCXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Chemocentryx Inc is a biopharmaceutical company engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CCXI 5.35 +0.05 +0.94% 229.45M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.